New real-world data presented at #IKCSNA26 shows belzutifan treatment more than halves the rate of tumor reduction procedures in patients with VHL disease, including a 70% drop in CNS surgeries, while showing strong long-term persistence! 🩺
Article: https://bit.ly/4AN8TSs
New real-world data presented at #IKCSNA26 shows belzutifan treatment more than halves the rate of tumor reduction procedures in patients with VHL disease, including a 70% drop in CNS surgeries, while showing strong long-term persistence! 🩺 Article: https://bit.ly/4AN8TSs
0 views
Published on 20/11/2026 18:31
0:10
New real-world data presented at #IKCSNA26 shows belzutifan treatment more than halves the rate of tumor reduction procedures in patients with VHL disease, including a 70% drop in CNS surgeries, while showing strong long-term persistence! 🩺
Article: https://bit.ly/4AN8TSs
0 comments
?